Europe Clears Roche Cancer Drug After Contamination Report
European regulators launched their inquiry after Roche last year revealed it had discovered L. licerasiae bacteria in bioreactors at a Vacaville, Calif., manufacturing plant.
According to the EMA, the contaminant, which can cause severe infections, was detected during a routine microscopic examination during early stages of production. The bacteria were not...
To view the full article, register now.